Article
Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.
Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2020
Hirokawa Tatsuya, Arimasu Yuu, Chiba Tomohiro, Nakazato Yoko, Fujiwara Masachika, Kamma Hiroshi
Abstract excerpt
BACKGROUND/AIM: The telomerase reverse transcriptase (TERT) promoter has a regulatory single nucleotide polymorphism (rSNP), rs2853669, and occasionally shows point mutations C228T and C250T. Although C228T and C250T have been well examined to increase TERT promoter activity and are known as risk factors for thyroid carcinoma, the significance of rs2853669 has not been well investigated. This study aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
